Allergan Aesthetics, an AbbVie company, launches Faces of Natrelle testimonial program
- AbbVie’s Allergan Aesthetics launched the nationwide Faces of Natrelle testimonial program.
- AbbVie executive Nicole Mowad‑Nassar says the program honors women’s implant stories and counters silence.
- AbbVie links participation to its Allē loyalty program, offering $500 cards for selected augmentation submissions.
Irvine, Calif., Feb. 3, 2026 — Allergan Aesthetics, an AbbVie company, announces the nationwide launch of the Faces of Natrelle® Testimonial Program, inviting eligible breast augmentation and reconstruction patients to share photos, videos and written testimonials. The program asks women who underwent surgery at age 22 or older to submit content for potential feature across Natrelle’s social media, website and other brand channels, positioning real patient stories as an educational resource for those considering aesthetic or reconstructive breast procedures.
Nicole Mowad-Nassar, president of Global Allergan Aesthetics and senior vice president at AbbVie, says the initiative is “about honoring the stories, the decisions, and the transformations of women with breast implants.” The company frames the program as an effort to counter what it describes as outdated perceptions and a lingering culture of silence around breast procedures, and to reflect diverse experiences that can offer clarity and confidence to prospective patients navigating both elective and medically indicated paths.
Selected augmentation participants who are members of AbbVie’s Allē® loyalty program may receive a $500 Allē gift card if their submissions are chosen and approved, with terms, eligibility limits and availability noted by the company; patients who underwent reconstruction are explicitly not eligible for compensation. Natrelle emphasizes that submissions should include a photo or video plus a written account of the patient’s experience with Natrelle Breast Implants, and that featured content will be used to inform and support others contemplating similar procedures.
Patient voices and stigma around breast procedures
Breast augmentation and reconstruction remain among the most popular cosmetic and reconstructive surgeries in the United States, and Allergan frames the Faces of Natrelle program as an attempt to normalize patient narratives and provide peer-driven information. The company highlights the program as part of a broader push to champion women’s voices at each step of the breast aesthetics journey, using firsthand accounts to supplement clinical information and provider consultations.
Related Cashu News

Bristol-Myers Squibb's Reclassification Enhances Growth Potential in Defensive Investment Strategy
Bristol-Myers Squibb Company (Ticker: BMY) undergoes a key reclassification across the Russell indexes, marking a transformative moment for the company. Moving to the Russell 1000 Defensive and Russel…

Vertex Pharmaceuticals' Casgevy Gains FDA Approval for Expanded Sickle Cell Disease Treatment Options
Vertex Pharmaceuticals (Ticker: VRTX) receives a significant boost in its ongoing battle against sickle cell disease with the recent FDA approval of an expanded label for its gene therapy product, Cas…

Gilead Sciences Gains FDA Approval for Trodelvy in First-Line Triple-Negative Breast Cancer Treatment
Gilead Sciences (Ticker: GILD) makes significant strides in oncology therapy with the recent approval of its drug Trodelvy for patients with unresectable or metastatic triple-negative breast cancer. T…

Merck Advances HIV Treatment and Faces Regulatory Scrutiny Amidst Market Success
Merck & Co. (Ticker: MRK) has recently made significant strides in the pharmaceutical landscape, particularly with its advancements in HIV treatment. The company's innovative drug, IDVYNSO, has receiv…

